Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas

Human Pathology

Volumn 45, Issue 8, 2014, Pages 1752-1758

  Liu, Bin ^a,d   Pang, Bo ^b   Hou, Xianzeng ^c   Fan, Haitao ^a   Liang, Nan ^a   Zheng, Shuai ^a   Feng, Bin ^a   Liu, Wei ^a   Guo, Hua ^a   Xu, Shangchen ^a   Pang, Qi ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Glioma; HMGA2; MIB 1 labeling index; MMP 2; Prognosis

Indexed keywords

GELATINASE A; HIGH MOBILITY GROUP A2 PROTEIN; KI 67 ANTIGEN;

ADULT; ARTICLE; CANCER CELL; CANCER GRADING; CANCER PROGNOSIS; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TUMOR INVASION; WESTERN BLOTTING;

GLIOMA; HMGA2; MIB-1 LABELING INDEX; MMP-2; PROGNOSIS;

ADULT; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GLIOMA; HMGA2 PROTEIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904684249     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.02.028     Document Type: Article

References (35)

1. S.M. Ranuncolo, M. Varela, and A. Morandi et al. Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas J Neurooncol 68 2004 113 121
2. P.Y. Wen, and S. Kesari Malignant gliomas in adults N Engl J Med 359 2008 492 507
3. K.L. Black, D. Yin, and J.M. Ong et al. PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model Brain Res 1230 2008 290 302
4. Y. Cui, Q. Wang, and J. Wang et al. Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells Brain Res 1469 2012 1 9
5. S.M. Kim, J.S. Woo, C.H. Jeong, C.H. Ryu, J.Y. Lim, and S.S. Jeun Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886 Cancer Res 7 2012 4807 4817
6. A. Fusco, and M. Fedele Roles of HMGA proteins in cancer Nat Rev Cancer 7 2007 899 910
7. R. Reeves, and L. Beckerbauer HMGI/Y proteins: flexible regulators of transcription and chromatin structure Biochim Biophys Acta 1519 2001 13 29
8. C. Rizzi, P. Cataldi, and A. Iop et al. The expression of the high-mobility group A2 protein in colorectal cancer and surrounding fibroblasts is linked to tumor invasiveness HUM PATHOL 44 2013 122 132
9. A. Malek, E. Bakhidze, and A. Noske et al. HMGA2 gene is a promising target for ovarian cancer silencing therapy Int J Cancer J 123 2008 348 356
10. K. Motoyama, H. Inoue, Y. Nakamura, H. Uetake, K. Sugihara, and M. Mori Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family Clin Cancer Res 14 2008 2334 2340
11. F. Di Cello, J. Hillion, and A. Hristov et al. HMGA2 participates in transformation in human lung cancer Mol Cancer Res 6 2008 743 750
12. F. Pentimalli, M. Dentice, and M. Fedele et al. Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2 Cancer Res 63 2003 7423 7427
13. A.L. Johannessen, and S.H. Torp The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas Pathol Oncol Res 12 2006 143 147
14. R. Du, C. Petritsch, and K. Lu et al. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM Neuro Oncol 10 2008 254 264
15. D.N. Louis, H. Ohgaki, and O.D. Wiestler et al. The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109
16. -ΔΔCt method Methods 25 2001 402 408
17. H. Xia, Y. Qi, and S.S. Ng et al. MicroRNA-146b inhibits glioma cell migration and invasion by targeting MMPs Brain Res 1269 2009 158 165
18. D.L. Silbergeld, and M.R. Chicoine Isolation and characterization of human malignant glioma cells from histologically normal brain J Neurosurg 86 1997 525 531
19. R.H. Goldbrunner, J.J. Bernstein, and J.C. Tonn Cell-extracellular matrix interaction in glioma invasion Acta Neurochir 141 1999 295 305
20. M. Kamino, M. Kishida, and T. Kibe et al. Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2 Cancer Sci 102 2011 540 548
21. B. Pang, H. Fan, and I.Y. Zhang et al. HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis J Neuro-Oncol 106 2012 543 549
22. D.A. Mayes, Y. Hu, and Y. Teng et al. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene Cancer Res 66 2006 9809 9817
23. H. Gao, B. Yu, and Y. Yan et al. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis J Neurosurg 118 2013 846 853
24. G. Kontogeorgos Predictive markers of pituitary adenoma behavior Neuroendocrinology 83 2006 179 188
25. R. Reeves Molecular biology of HMGA proteins: hubs of nuclear function Gene 277 2001 63 81
26. M. Narita, V. Krizhanovsky, and S. Nunez et al. A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation Cell 126 2006 503 514
27. P. Rogalla, K. Drechsler, and G. Frey et al. HMGI-C expression patterns in human tissues: implications for the genesis of frequent mesenchymal tumors Am J Pathol 149 1996 775 779
28. T. Sanosaka, M. Namihira, and H. Asano et al. Identification of genes that restrict astrocyte differentiation of midgestational neural precursor cells Neuroscience 155 2008 780 788
29. A. Banerji, J. Chakraborti, A. Mitra, and A. Chatterjee Cell membrane-associated MT1-MMP-dependent activation of pro-MMP-2 in A375 melanoma cells J Environ Pathol Toxicol Oncol 24 2005 3 17
30. S. Chakraborti, M. Mandal, S. Das, A. Mandal, and T. Chakraborti Regulation of matrix metalloproteinases: an overview Mol Cell Biochem 253 2003 269 285
31. S. Dangi-Garimella, S.B. Krantz, and M.R. Barron et al. Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2 Cancer Res 71 2011 1019 1028
32. G. Mu, H. Liu, and F. Zhou et al. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas HUM PATHOL 41 2010 493 502
33. Z.R. Qian, S.L. Asa, and H. Siomi et al. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas Mod Pathol 22 2009 431 441
34. T. Akai, Y. Ueda, and Y. Sasagawa et al. High mobility group I-C protein in astrocytoma and glioblastoma Pathol Res Pract 200 2004 619 624
35. Y. Liu, S. Shete, and C.J. Etzel et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival J Clin Oncol 28 2010 2467 2474